Phase Ib Trial Shows 40 Percent of Patients Receiving Keytruda Alive After 36-Month Follow Up June 02, 2016Vol.- No.-
Drugs & Targets FDA Grants Approvals to Tecentriq, Opdivo, Imbruvica, Lenvima June 02, 2016Vol.- No.-
Cancers Originating on Left Side of Colon Associated with Longer Survival, Study Says June 02, 2016Vol.- No.-
Researchers: Radiation After Surgery Benefits Older Patients More than Younger Patients May 02, 2016Vol.- No.-
